Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers
Authors:
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 32 (2) , 267-276
Abstract
No abstract availableKeywords
Funding Information
- Asper Endowment Foundation
- St. Boniface Research Foundation
This publication has 42 references indexed in Scilit:
- The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma PatientsJACC: Heart Failure, 2013
- Left and right ventricular strain and strain rate measurement in normal adults using velocity vector imaging: an assessment of reference values and intersystem agreementThe International Journal of Cardiovascular Imaging, 2012
- Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated PatientsThe American Journal of Cardiology, 2011
- Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 LevelsHypertension, 2010
- Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibThe Lancet, 2007
- Tissue Doppler ImagingJACC, 2007
- Angiogenesis: an organizing principle for drug discovery?Nature Reviews Drug Discovery, 2007
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Detection of anthracycline-induced cardiotoxicityCancer Treatment Reviews, 1999
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979